[go: up one dir, main page]

AU2001225479A1 - Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs - Google Patents

Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs

Info

Publication number
AU2001225479A1
AU2001225479A1 AU2001225479A AU2547901A AU2001225479A1 AU 2001225479 A1 AU2001225479 A1 AU 2001225479A1 AU 2001225479 A AU2001225479 A AU 2001225479A AU 2547901 A AU2547901 A AU 2547901A AU 2001225479 A1 AU2001225479 A1 AU 2001225479A1
Authority
AU
Australia
Prior art keywords
molecular weight
eem
yucatensiswith
lucidumand
speciosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001225479A
Inventor
Akiko Ikekawa
Tetsuro Ikekawa
Fumitake Shimada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Science Laboratories Co Ltd
Original Assignee
LIFE SCIENCE LAB CO Ltd
Life Science Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIFE SCIENCE LAB CO Ltd, Life Science Laboratories Co Ltd filed Critical LIFE SCIENCE LAB CO Ltd
Publication of AU2001225479A1 publication Critical patent/AU2001225479A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Preparation Of Fruits And Vegetables (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

EEM-S having a molecular weight of 6000-60000 and obtained by: (i) extracting organisms such as Lentinus edodes, Flammulina velutipes, Hypsizigus marmoreus, Ganoderma lucidumand/or Phellinus yucatensiswith hot water or lower alcohol; and (ii) treating the extract with molecular sieves to remove the low molecular weight and high molecular weight fractions. EEM-S is claimed having a molecular weight of 6000-60000 and obtained by: (i) extracting Lentinus edodes, Flammulina velutipes, Hypsizigus marmoreus, Pleurotus ostreatus, Pholiota nameko, Grifola fondosa, Volvariella speciosa var.speciosa, Lyophyllum decastes, blanc du pays, Tricholoma matsutake, Ganoderma lucidumand/or Phellinus yucatensiswith hot water or lower alcohol; and (ii) treating the extract with molecular sieves to remove the low molecular weight and high molecular weight fractions. ACTIVITY : Cytostatic; immunostimulator; hypotensive; antidiabetic. EEM-SB administered to mice implanted with BDF 1cells at 500 mg/kg/day for 20 days increased survival time by 45.8%. MECHANISM OF ACTION : Antioxidant; hypoglycemic.
AU2001225479A 2000-01-12 2001-01-11 Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs Abandoned AU2001225479A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000037220 2000-01-12
JP2000/37220 2000-01-12
PCT/JP2001/000072 WO2001051070A1 (en) 2000-01-12 2001-01-11 Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs

Publications (1)

Publication Number Publication Date
AU2001225479A1 true AU2001225479A1 (en) 2001-07-24

Family

ID=18561141

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001225479A Abandoned AU2001225479A1 (en) 2000-01-12 2001-01-11 Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs

Country Status (9)

Country Link
US (1) US6783771B2 (en)
EP (1) EP1247529B1 (en)
JP (1) JP4728551B2 (en)
KR (1) KR100858569B1 (en)
CN (1) CN100346796C (en)
AT (1) ATE311896T1 (en)
AU (1) AU2001225479A1 (en)
DE (1) DE60115596T2 (en)
WO (1) WO2001051070A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049308A1 (en) * 2000-01-05 2001-07-12 Kureha Chemical Industry Co., Ltd. Novel immune enhancing compositions
NO20014256D0 (en) 2001-09-03 2001-09-03 Bjoern Kristiansen Preparation of immunostimulatory compound
IL146737A (en) * 2001-11-26 2010-02-17 Lycored Natural Prod Ind Ltd Method for protecting lycopene dispersed in tomato fibers
KR20040033104A (en) * 2002-10-11 2004-04-21 내츄럴네오팜(주) Anticancer composition using natural plant extracts
KR20040057973A (en) * 2002-12-26 2004-07-02 요시노부 기타지마 A method for culturing a Pleurotus nebrodensis strain and an improving agent for prevention of disease comprising said strain
KR20050001730A (en) * 2003-06-26 2005-01-07 진주버섯영농조합 Composition for prevention and treatment of cancer
JP2007166903A (en) * 2003-07-31 2007-07-05 Takara Bio Inc Antitumor composition
JP2005075740A (en) * 2003-08-28 2005-03-24 Hajime Otani Immunopotentiating composition, and pharmaceutical, animal drug, food, fodder and cosmetic containing the same
JP4618770B2 (en) * 2004-02-12 2011-01-26 株式会社クレハ Novel antihypertensives and foods
US7514085B2 (en) 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
KR100590999B1 (en) * 2004-10-22 2006-06-19 주식회사 케이티앤지 Antitumor pharmaceutical composition containing red ginseng acid polysaccharide and shiitake mushroom
KR100663712B1 (en) 2005-05-24 2007-01-03 (주)새롬바이오 Extracellular polysaccharide with antidiabetic activity obtained from mycelium of situation mushroom and its manufacturing method
WO2006126488A1 (en) * 2005-05-25 2006-11-30 Unitika Ltd. Cauliflower mushroom extract
WO2006133707A2 (en) 2005-06-15 2006-12-21 Medimush A/S Anti-cancer combination treatment and kit-of-part
TW200726843A (en) * 2005-07-13 2007-07-16 Botan Bioscience Corp Methods for the administration of FV and related compositions
KR100673051B1 (en) * 2005-07-29 2007-01-22 양병근 Intracellular Biopolymers Isolated from Taste Mushroom Mycelium Liquid Cultures with Immune Enhancing Activity
KR100729213B1 (en) * 2005-07-29 2007-06-19 주식회사 라이벌코리아 Extracellular Biopolymers Isolated from Liquid Cultures of Leafy Mushrooms with Immune Enhancing Activity
JP2007031665A (en) * 2005-07-29 2007-02-08 Yukiguni Maitake Co Ltd Glycoprotein extracted from grifola frondosa
US7597910B2 (en) * 2005-08-20 2009-10-06 Slgm Medical Research Institute Compositions and methods for treating prostate disorders
CN100412186C (en) * 2006-03-31 2008-08-20 浙江大学 Method for preparing Phyllopyreum thallus by Phyloporus xylophilus and liquid submerged fermentation
JP5063040B2 (en) * 2006-06-30 2012-10-31 ユニチカ株式会社 Angiogenesis inhibitor
JP2008106018A (en) 2006-10-27 2008-05-08 Yukiguni Maitake Co Ltd Maitake-derived substance having anti-influenza virus activity and method for producing the same
US20100255024A1 (en) * 2007-12-07 2010-10-07 Hankook Pharm. Co., Inc. Composition for inhibition of transplant rejection containing the phellinus linteus mycellia extract as an active ingredient
US8071105B2 (en) * 2008-04-21 2011-12-06 Academia Sinica Reishi F3 sub fraction polysaccharides and methods of using same
JP2012077004A (en) * 2010-09-30 2012-04-19 Tokyo Institute Of Technology Insulin secretion promoter, agent for preventing/ameliorating diabetes, comprising the same as main component or containing the same and food for preventing/ameliorating diabetes
CN103272216B (en) * 2013-05-30 2015-11-25 北京市农林科学院 Pleurotus citrinopileatus protein extract and antineoplastic application thereof
US10092609B2 (en) 2015-01-16 2018-10-09 James A. Wieser Process for preparing medicinal mycological preparations
CN106591116A (en) * 2016-11-22 2017-04-26 大连大学 Reaction device capable of eliminating inhibiting effect of enzymolysis product on enzymatic activity

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5657716A (en) 1979-10-16 1981-05-20 Morinaga & Co Ltd Pharmaceutical composition derived from fomes japonicus
JPS56127317A (en) 1980-03-11 1981-10-06 Banyu Pharmaceut Co Ltd Preparation of carcinostatic substance
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPS58118519A (en) * 1981-12-29 1983-07-14 Noda Shiyokukin Kogyo Kk Anticancer agent
JPS6023392A (en) * 1983-07-15 1985-02-05 Yamajirushi Jozo Kk Extract of flammulina velutipes
JPS6023391A (en) * 1983-07-15 1985-02-05 Yamajirushi Jozo Kk Extract of flammulina velutipes
JPS6219530A (en) 1985-07-19 1987-01-28 Toyo Soda Mfg Co Ltd Glycoprotein complex and production thereof
JPS6372629A (en) 1986-09-17 1988-04-02 Kyoritsu Yakuhin Kogyo Kk Production of physiologically active extract from ganoderma lucidum karst.
DE3886986T2 (en) * 1987-04-28 1994-08-11 Meiji Milk Prod Co Ltd Glycoprotein, process for its preparation and immunosuppressive agent containing it as an active ingredient.
CN1032428C (en) * 1992-08-15 1996-07-31 樊菊芬 New process for extracting lentinan or lentinan
JP2767521B2 (en) * 1992-09-04 1998-06-18 農林水産省食品総合研究所長 Novel antitumor protein, method for producing the same, and antitumor agent containing the protein as active ingredient
JPH08291078A (en) * 1995-04-21 1996-11-05 M I O:Kk Mushroom protein for food and beverage effective in preventing and treating hypertension and hyperlipemia and having antitumor action, mushroom protein for food and beverage effective in preventing and treating obesity and having antitumor action and method for extracting these proteins
US5714464A (en) * 1995-08-09 1998-02-03 Wisconsin Alumni Research Foundation Anti-viral mushroom extracts
CN1069650C (en) * 1995-12-29 2001-08-15 中国科学院上海药物研究所 Method for separation and purification of lentinan
JPH09315994A (en) * 1996-05-29 1997-12-09 Sumitomo Forestry Co Ltd Antitumor active substance
US5711948A (en) * 1996-05-29 1998-01-27 Pospelova; Olga L. Plant-derived, biologically active polysaccharides and method of preparing same
JPH11302191A (en) * 1998-04-20 1999-11-02 Eishogen:Kk Immunostimulant and antitumor agent containing Hatake Shimeji extract as active ingredient
JP2000159808A (en) 1998-11-27 2000-06-13 Kobayashi Pharmaceut Co Ltd Method for separating and purifying basidiomycota hypha extract
US6440420B1 (en) * 2001-03-19 2002-08-27 Xin Liu Method for extracting oleaginous substances from germination-activated Ganoderma lucidum spores

Also Published As

Publication number Publication date
CN1416349A (en) 2003-05-07
EP1247529A1 (en) 2002-10-09
DE60115596D1 (en) 2006-01-12
EP1247529B1 (en) 2005-12-07
KR20020063618A (en) 2002-08-03
JP4728551B2 (en) 2011-07-20
US20030012798A1 (en) 2003-01-16
ATE311896T1 (en) 2005-12-15
DE60115596T2 (en) 2006-06-14
CN100346796C (en) 2007-11-07
WO2001051070A1 (en) 2001-07-19
US6783771B2 (en) 2004-08-31
KR100858569B1 (en) 2008-09-17
EP1247529A4 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
AU2001225479A1 (en) Physiologically active substance eem-s originating in mushrooms, process for producing the same and drugs
Vetter Biological values of cultivated mushrooms—A review
EP3355683B1 (en) Method of producing mushrooms
Wasser et al. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective
Smith et al. Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities
Thakur et al. Mushrooms, their bioactive compounds and medicinal uses: A review
US6805866B2 (en) Oral supplement composition containing a plurality of mushroom strains
Mori et al. Antitumor activities of edible mushrooms by oral administration
US11857587B2 (en) Bioactive extract
Sridhar et al. Evaluation of antibacterial and antifungal activity of Ganoderma lucidum (Curtis) P. Karst fruit bodies extracts
CN105168173A (en) Fungi polysaccharide complex anticancer and cancer prevention and treatment drug
Lien Fungal metabolites and Chinese herbal medicine as immunostimulants
Sułkowska-Ziaja et al. Biologically active compounds of fungal origin displaying antitumor activity
Yoo et al. Trends of mushroom science and mushroom industry
Kakraliya Economic importance of mushroom and their uses
KR20030030636A (en) Manufacturing method of highly active antitumor protein-polysaccharides using fermentation of the fruit bodies of mushroom
TWI353247B (en) Use of tremella polysaccharide for prevention and/
JP4368540B2 (en) Osteomalacia preventive agent
RU2003105593A (en) BIOLOGICALLY ACTIVE ADDITIVE FOR THE PRODUCTION OF COSMETIC COMPOSITIONS
Park Industrialization of mushroom functional substances
JP4422881B2 (en) Anti-cancer side effect reducing composition
CN212464322U (en) Inoculation device is used in apricot bao mushroom production
Galena et al. Mushrooms and the prevention and treatment of cancer.
Kwag et al. aau me {feel are awn 731
KR810000257B1 (en) Method of extracting antioncogenic nitrogen-containing polysaccharides